bluebird bio Reports Second Quarter 2019 Financial Results and Highlights Operational Progress
– Received EU conditional marketing authorization for ZYNTEGLO® (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years…
Pharmaceuticals, Biotechnology and Life Sciences
– Received EU conditional marketing authorization for ZYNTEGLO® (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
Company Reports $3.0 Million in Net Product Revenues from COPIKTRA®; Raises Product Revenue Guidance for 2019 Cash, Cash Equivalents and…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…
MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune…
SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health Solutions, Inc., a pioneer in advanced healthcare analytics and care optimization, is pleased to announce that…
Respected scientific expert and motivator recognized for dedication to bringing clinical trials to life in rare and orphan diseases RESEARCH…
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Therapeutics/Drug Market Analysis By Class (Anti-allergy, Anti-VEGF Agents, Anti-inflammatory, Anti-glaucoma), By Disease (Dry Eye, Allergies, Glaucoma, Infection,…
DUBLIN–(BUSINESS WIRE)–The “Hemophilia Market Analysis By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement…
Noted Physician-Scientist Brings Far-Reaching Expertise CAMBRIDGE, Mass.–(BUSINESS WIRE)–Glympse Bio, Inc., a life science company developing in vivo activity sensors to…